Abstract
Purpose
Excess embryos transferred (ET) (> plurality at birth) and fetal heartbeats (FHB) at 6 weeks’ gestation are associated with reductions in birthweight and gestation, but prior studies have been limited by small sample sizes and limited IVF data. This analysis evaluated associations between excess ET, excess FHB, and adverse perinatal outcomes, including the risk of nonchromosomal birth defects.
Methods
Live births conceived via IVF from Massachusetts, New York, North Carolina, and Texas included 138,435 children born 2004–2013 (Texas), 2004–2016 (Massachusetts and North Carolina), and 2004–2017 (New York) were classified by ET and FHB. Major birth defects were reported by statewide registries within the first year of life. Logistic regression was used to estimate adjusted odds ratios (AORs) and 95% CIs of the risks of a major nonchromosomal birth defect, small-for-gestational age birthweight (SGA), low birthweight (LBW), and preterm birth (≤36 weeks), by excess ET, and excess ET + excess FHB, by plurality at birth (singletons and twins).
Results
In singletons with [2 ET, FHB =1] and [≥3 ET, FHB=1], risks [AOR (95% CI)] were increased, respectively, for major nonchromosomal birth defects [1.13 (1.00–1.27) and 1.18 (1.00–1.38)], SGA [1.10 (1.03–1.17) and 1.15 (1.05–1.26)], LBW [1.09 (1.02–1.13) and 1.17 (1.07–1.27)], and preterm birth [1.06 (1.00–1.12) and 1.14 (1.06–1.23)]. With excess ET + excess FHB, risks of all adverse outcomes except major nonchromosomal birth defects increased further for both singletons and twins.
Conclusion
Excess embryos transferred are associated with increased risks for nonchromosomal birth defects, reduced birthweight, and prematurity in IVF-conceived births.
Similar content being viewed by others
Data availability
The data used in this analysis were obtained from private (SART CORS) and public (vital records, birth defects registries) sources, under data use agreements and confidentiality pledges assuring that the data would not be shared or distributed, and therefore are not available to other investigators.
References
Toner J, Coddington CC, Doody K, van Voorhis B, Seifer D, Ball GD, et al. SART & ART in the US: a 2016 update. Fertil Steril. 2016;106(3):541–6.
Centers for Disease Control and Prevention. Assisted Reproductive Technology Fertility Clinic Success Rates Report. Atlanta: US Department of Health and Human Services; 2016. p. 2018.
Barton SE, Missmer SA, Hornstein MD. Twin pregnancies with a ‘vanished’ embryo: a higher risk multiple gestation group? Hum Reprod. 2011;26:2750–3.
Evron E, Sheiner E, Friger M, Sergienko R, Harlev A. Vanishing twin syndrome: is it associated with adverse perinatal outcome? Fertil Steril. 2015;103:1209–14.
La Sala GB, Nucera G, Gallinelli A, Nicoli A, Villani MT, Blickstein I. Lower embryonic loss rates among twin gestations following assisted reproduction. J Assist Reprod Genet. 2005;22:181–4.
Mansour R, Serour G, Aboulghar M, Kamal O, Al-Inany H. The impact of vanishing fetuses on the outcome of ICSI pregnancies. Fertil Steril. 2010;94:2430–2.
Márton V, Zádori J, Kozinszky Z, Keresztúri A. Prevalences and pregnancy outcome of vanishing twin pregnancies achieved by in vitro fertilization versus natural conception. Fertil Steril. 2016;106:1399–406.
Romanski PA, Carusi DA, Farland LV, Missmer SA, Kaser DJ, Walsh BW, et al. Perinatal and peripartum outcomes in vanishing twin pregnancies achieved by in vitro fertilization. Obstet Gynecol. 2018;131:1011–20.
Shebl O, Ebner T, Sommergruber M, Sir A, Tews G. Birth weight is lower for survivors of the vanishing twin syndrome: a case-control study. Fertil Steril. 2008;90:310–4.
Zhou L, Gao X, Yu W, Zhang Z. Analysis of pregnancy outcomes for survivors of the vanishing twin syndrome after in vitro fertilization and embryo transfer. Eur J Obstet Gynecol Reprod Biol. 2016;203:35–9.
Pinborg A, Lidegaard Ø, la Cour FN, Andersen AN. Consequences of vanishing twins in IVF/ICSI pregnancies. Hum Reprod. 2005;20:2821–9.
Pinborg A, Lidegaard Ø, la Cour FN, Andersen AN. Vanishing twins: a predictor of small-for-gestational age in IVF singletons. Hum Reprod. 2007;22:2707–14.
Luke B, Brown MB, Grainger DA, Stern JE, Klein N, Cedars MI. The effect of early fetal losses on singleton assisted-conception pregnancy outcomes. Fertil Steril. 2009;91:2578–85.
Luke B, Brown MB, Grainger DA, Stern JE, Klein N, Cedars MI. The effect of early fetal losses on twin assisted-conception pregnancy outcomes. Fertil Steril. 2009;91:2586–92.
Luke B, Brown MB, Stern JE, Grainger DA, Klein N, Cedars M. Effect of embryo transfer number on singleton and twin implantation pregnancy outcomes after assisted reproductive technology. J Reprod Med. 2010;55:387–94.
Luke B, Stern JE, Kotelchuck M, Declercq ER, Hornstein MD, Gopal D, et al. Adverse pregnancy outcomes after in vitro fertilization: effect of number of embryos transferred and plurality at conception. Fertil Steril. 2015;104:79–86.
Spector LG, Brown MB, Wantman E, Letterie GS, Toner JP, Doody KJ, et al. Risk of childhood cancer after in vitro fertilization in the United States. JAMA Pediatr. 2019;173:e190392. https://doi.org/10.1001/jamapediatrics.2019.0392.
Martin JA, Hamilton BE, Osterman MJK, Driscoll AK, Drake P. Births: final data for 2017. In: National vital statistics reports, vol. 67, no. 8. Hyattsville: National Center for Health Statistics; 2018.
Sunderam S, Kissin DM, Zhang Y, Folger SG, Boulet SL, Warner L, et al. Assisted reproductive technology surveillance—United States, 2016. Morb Mortal Wkly Rep Surveill Summ. 68(4):1–23.
Centers for Disease Control and Prevention. Assisted Reproductive Technology Fertility Clinic Success Rates Report. Atlanta: US Department of Health and Human Services; 2017. p. 2019.
Practice Committee of the American Society for Reproductive Medicine and the Practice Committee of the Society for Assisted Reproductive Technology. Guidance on the limits to the number of embryos to transfer: a committee opinion. Fertil Steril. 2017;107:901–3.
National Birth Defects Prevention Network (NBDPN). In: Sever LE, editor. Guidelines for conducting birth defects surveillance. Atlanta: National Birth Defects Prevention Network, Inc; 2004.
Land JA. How should we report on perinatal outcomes? Hum Reprod. 2006;21:2638–9.
Talge NM, Mudd LM, Sikorskii A, Basso O. United States birth weight reference corrected for implausible gestational age estimates. Pediatrics. 2014;133:844–53.
Luke B, Brown MB, Wantman E, Forestieri NE, Browne ML, Fisher SC, et al. The risk of birth defects with conception by ART. Hum Reprod. 2020 (in press). https://doi.org/10.1093/humrep/deaa272.
Berntsen S, Söderström-Anttila V, Wennerholm UB, Laivuori H, Loft A, Oldereid NB, et al. The health of children conceived by ART: ‘the chicken or the egg?’. Hum Reprod Update. 2019;25:137–58.
Dickey RP, Taylor SN, Lu PY, Sartor BM, Storment JM, Rye PH, et al. Spontaneous reduction of multiple pregnancy: incidence and effect on outcome. Am J Obstet Gynecol. 2002;186:77–83.
Tummers P, De Sutter P, Dhont M. Risk of spontaneous abortion in singleton and twin pregnancies after IVF/ICSI. Hum Reprod. 2003;18:1720–3.
Kamath MS, Antonisamy B, Selliah HY, Sunkara SK. Perinatal outcomes of singleton live births with and without vanishing twin following transfer of multiple embryos: analysis of 113,784 singleton live births. Hum Reprod. 2018;33:2018–22.
Magnus MC, Ghaderi S, Morker NH, Magnus P, Romundstad LB, Skjærven R, et al. Vanishing twin syndrome among ART singletons and pregnancy outcomes. Hum Reprod. 2017;32:2298–304.
Petrini AC, Pereira N, Lekovich JP, Elias RT, Spandorfer SD. Early spontaneous multiple fetal pregnancy reduction is associated with adverse perinatal outcomes in in vitro fertilization cycles. Women Health. 2016;12:420–6.
Yan J, Guan Y, Fan H, Mu M, Sun S, Geng W, et al. Neonatal outcomes of singleton live births with vanishing twin syndrome following double embryos transfer in assisted reproductive technology: a retrospective cohort study. J Ovarian Res. 2019;12:67. https://doi.org/10.1186/s13048-019-0539-8.
Ebbing C, Kiserud T, Johnsen SL, Albrechtsen S, Rasmussen S. Prevalence, risk factors and outcomes of velamentous and marginal cord insertions: a population-based study of 634,741 pregnancies. PLoS One. 2013;8(7):e70380.
Sacha CR, Harris AL, James K, Basnet K, Freret TS, Yeh J, et al. Placental pathology in live births conceived with in vitro fertilization after fresh and frozen embryo transfer. Am J Obstet Gynecol. 2020;222:360.e1–e16.
Harris AL, Sacha CR, Basnet KM, James KE, Freret TS, Kaimal AJ, et al. Vanishing twins conceived through fresh in vitro fertilization. Obstet Gynecol. 2020;135:1426–33.
Luke B, Brown MB, Stern JE, Jindal SK, Racowsky C, Ball GD. Using the Society for Assisted Reproductive Technology Clinic Outcome System morphological measures to predict live birth after assisted reproductive technology. Fertil Steril. 2014;102(5):1338–44.
Pharoah POD, Cooke RWI. A hypothesis for the etiology of spastic cerebral palsy—the vanishing twin. Dev Med Child Neurol. 1997;39:292–6.
Glinianaia SV, Pharoah POD, Wright C, Rankin JM, on behalf of the Northern Region Perinatal Mortality Survey Steering Group. Fetal or infant death in twin pregnancy: neurodevelopmental consequence for the survivor. Arch Dis Child Neonatal Ed. 2002;86:F9–F15.
Pharoah POD, Price TS, Plomin R. Cerebral palsy in twins: a national study. Arch Dis Child Neonatal Ed. 2002;87:F122–4.
Murray E, Fernandes M, Fazel M, Kennedy SH, Villar J, Stein A. Differential effect of intrauterine growth restriction on childhood neurodevelopment: a systematic review. Br J Obstet Gynaecol. 2015;122:1062–72.
Mericq V, Martinez-Aguayo A, Uauy R, Iniguez G, Van der Steen M, Hokken-Koelega A. Long-term metabolic risk among children born premature or small for gestational age. Nat Rev Endocrinol. 2017;13:50–62.
Acknowledgements
The authors thank the Society for Assisted Reproductive Technology and all of its members for providing clinical information to the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for use by patients and researchers. Without the efforts of their members, this research would not have been possible.
Funding
This project was supported by grant R01 HD084377 from the National Institute of Child Health and Human Development National Institutes of Health, USA (Barbara Luke, Principal Investigator).
Author information
Authors and Affiliations
Contributions
Drs. Luke and Brown had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Luke and Brown
Acquisition, analysis, or interpretation of data: All authors
Drafting of the manuscript: Luke, Brown
Critical revision of the manuscript for important intellectual content: All authors
Statistical analysis: Brown
Obtained funding: Luke, Brown
Administrative, technical, or material support: All authors
Supervision: Luke
Corresponding author
Ethics declarations
Ethics approval
This study was approved by the Institutional Review Boards at Michigan State University, the University of Michigan, and each of the four study State Departments of Health.
Conflict of interest
Drs. Luke and Brown reported receiving grants from NIH during the conduct of the study. Ms. Forestieri, Dr. Yazdy, and Dr. Browne reported receiving NIH grant support from Michigan State University during the conduct of the study. Mr. Wantman reported receiving personal fees from SART, being a data vendor of SART, and maintaining the SART CORS database during the course of the study; and personal fees from NYU Fertility, MyEggBank, Prelude Fertility, Shady Grove Fertility, Northwell Health Fertility, and Mass General Fertility outside the submitted work. No other disclosures were reported.
Disclaimer
The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Child Health and Human Development, or the National Institutes of Health, nor any of the State Departments of Health which contributed data.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
ESM 1
(DOCX 53 kb)
Rights and permissions
About this article
Cite this article
Luke, B., Brown, M.B., Wantman, E. et al. Risks of nonchromosomal birth defects, small-for-gestational age birthweight, and prematurity with in vitro fertilization: effect of number of embryos transferred and plurality at conception versus at birth. J Assist Reprod Genet 38, 835–846 (2021). https://doi.org/10.1007/s10815-021-02095-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-021-02095-3